# Sex-specific association of visceral adiposity index with renal dysfunction in chinese type 2 diabetes: A cross-sectional study

**Authors:** Songfang Liu, Louyan Ma, Yu Niu, Ranran Ma, Ting Qi, Bingyin Shi, Aleksandra Klisic, Aleksandra Klisic, Aleksandra Klisic, Aleksandra Klisic

PMC · DOI: 10.1371/journal.pone.0343375 · PLOS One · 2026-02-25

## TL;DR

The study finds that visceral adiposity index is strongly linked to kidney dysfunction in Chinese men with type 2 diabetes, but not in women.

## Contribution

The study identifies sex-specific differences in how visceral adiposity relates to kidney function in Chinese type 2 diabetes patients.

## Key findings

- Visceral adiposity index is a significant predictor of renal dysfunction in Chinese male T2DM patients.
- Female associations between adiposity indices and kidney function are largely explained by confounding factors.
- Sex-stratified analysis reveals distinct clinical implications for male and female diabetic patients.

## Abstract

Diabetic nephropathy is a serious microvascular complication of type 2 diabetes mellitus, yet the sex-specific relationship between visceral adiposity and renal dysfunction remains insufficiently explored in Chinese populations.

To investigate the association between visceral adiposity indices and renal dysfunction in Chinese type 2 diabetes mellitus patients, emphasizing this population’s unique risk profile and the clinical utility of composite adiposity measures.

This cross-sectional study involved 1,335 type 2 diabetes mellitus patients. The primary outcome variable was renal dysfunction, defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m². Thirteen visceral adiposity indices were evaluated through correlation analysis, overall population regression modeling, and sex-stratified approaches. Multiple regression models were progressively adjusted for demographic characteristics, lifestyle factors, clinical parameters, and medications to assess independent associations with estimated glomerular filtration rate.

The study population (median age: 54 years; 67.04% male) demonstrated distinct characteristics between estimated glomerular filtration rate groups. The estimated glomerular filtration rate decline group exhibited significantly higher age, blood pressure, and fasting glucose compared to the normal group (all p < 0.05). Despite similar body mass index levels, multiple visceral adiposity indices (waist-to-hip ratio, lipid accumulation product, Chinese visceral adiposity index, visceral adiposity index, body roundness index, relative fat mass, and metabolic score for visceral fat) were significantly elevated in the eGFR Decline Group. Comprehensive correlation analysis revealed substantial attenuation after confounder adjustment, with only visceral adiposity index maintaining significance in the total population (adjusted r = −0.075, p = 0.007). Multivariate regression confirmed visceral adiposity index as the most robust predictor (β = −1.63, 95% CI: −2.75 to −0.50, p = 0.0048). Sex-stratified analyses revealed profound differences: visceral adiposity index demonstrated independent predictive value exclusively in males (β = −2.41, 95% CI: −3.84 to −0.98, p = 0.001), while all female associations became non-significant after full adjustment.

Visceral adiposity index showed strong and consistent associations with renal dysfunction specifically in Chinese male T2DM patients, while female associations were primarily mediated through confounding pathways. These findings highlight critical sex-specific differences and support the integration of composite visceral adiposity indices into routine clinical assessment for male diabetic patients, emphasizing the necessity of population-specific and gender-tailored approaches in renal risk stratification.

## Linked entities

- **Diseases:** type 2 diabetes mellitus (MONDO:0005148), diabetic nephropathy (MONDO:0005016)

## Full-text entities

- **Genes:** ETV3 (ETS variant transcription factor 3) [NCBI Gene 2117] {aka METS, PE-1, PE1}, BP1 [NCBI Gene 474256], LAP (Laryngeal adductor paralysis) [NCBI Gene 7939], FLII (FLII actin remodeling protein) [NCBI Gene 2314] {aka CMD2J, FLI, FLIL, Fli1}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}
- **Diseases:** Insulin Resistance (MESH:D007333), cardiovascular disease (MESH:D002318), systemic (MESH:D015619), CVAI (MESH:C562377), adiposity (MESH:D018205), Renal Disease (MESH:D007674), heart failure (MESH:D006333), organ damage (MESH:D000092124), T2DM (MESH:D003924), EPS (MESH:D001480), Diabetic nephropathy (MESH:D003928), metabolic syndrome (MESH:D024821), inflammation (MESH:D007249), ORCID iD (MESH:C535742), CKD (MESH:D051436), malignancy (MESH:D009369), Diabetes (MESH:D003920), endothelial dysfunction (MESH:D014652), renal function decline (MESH:D060825), deterioration of renal function (MESH:D058186), obesity (MESH:D009765), fatty liver (MESH:D005234), METS-VF (MESH:D007418), RFM (MESH:C536030), declining kidney function (MESH:D007680), metabolic (MESH:D008659)
- **Chemicals:** TG (MESH:D013866), FPG (-), Lipid (MESH:D008055), Glucose (MESH:D005947), alcohol (MESH:D000438), Diastolic Blood Pressure (MESH:D004145), Triglycerides (MESH:D014280), Cholesterol (MESH:D002784)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12935224/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12935224/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12935224/full.md

---
Source: https://tomesphere.com/paper/PMC12935224